University Times

Magee-Womens Hospital has launched a lymphedema screening, early detection and prevention program to help breast cancer patients with the most potential for developing this treatment-related complication.

Lymphedema, one of the most common complications breast cancer patients face, is a chronic and progressive condition that causes swelling in the limbs, increasing a patient’s risk for infection and often affecting quality of life.

Atilla Soran, professor of surgery in the School of Medicine, is director of the program, which will incorporate bioimpedance spectroscopy technology created by ImpediMed Ltd. to aid in the clinical assessment of at-risk breast cancer patients. This technology can measure extracellular fluid accurately in a patient’s limb, which can assist physicians in assessing early signs of lymphedema. Patients who participate in the program will have their arms measured for swelling before treatment and at regular intervals afterward because lymphedema can occur weeks, months and even years after treatment.

The highest incidence of lymphedema in the United States occurs following breast cancer surgery, particularly among those who undergo radiation therapy following lymph node surgery. Among this group, up to 30 percent of patients develop some degree of upper extremity lymphedema.

Funding to start the program was provided by the Magee-Womens Hospital Volunteer Service Board.